🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Status
Completed
Location
Sihanouk Hospital Center of Hope
Start Date
2014-09
Trial ID
NCT02057796
The primary objective of this study is to evaluate the non-inferiority of s...
Status
Completed
Location
Maricopa Integrated Health System
Start Date
2015-01-26
Trial ID
NCT02345226
Treatments Being Tested
This is a phase IV, open label, multicentre trial that will be taking place...
Status
Unknown
Location
Chelsea and Westminster Hospital
Start Date
2014-11
Trial ID
NCT02285374
Treatments Being Tested
The primary objective of this study is to assess glomerular function before...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-15
Trial ID
NCT02246998
Atripla (ATP: FTC/TDF/EFV) was the first single pill treatment for HIV and ...
Status
Terminated
Location
University of Alberta
Start Date
2018-10-29
Trial ID
NCT03532425
Treatments Being Tested
The purpose of this study is to compare the antiretroviral activity of dora...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-05
Trial ID
NCT02403674
Treatments Being Tested
The purpose of the study is to investigate the benefits of switching away f...
Status
Completed
Location
St Stephen's Centre
Start Date
2010-10
Trial ID
NCT01195467
Treatments Being Tested
Bioequivalence study of two formulations containing a fixed dose combinatio...
Status
Completed
Location
DominguezLab
Start Date
2016-09-04
Trial ID
NCT03309566
Treatments Being Tested
The purpose of the study is to look at the levels of three HIV medications:...
Status
Completed
Location
St Stephen's Centre
Start Date
2010-06
Trial ID
NCT01108926
Treatments Being Tested
This study evaluates the efficacy, safety and tolerability of switching fro...
Status
Completed
Location
Midland Research Group, Inc
Start Date
2018-03-01
Trial ID
NCT03502005
Treatments Being Tested